HealthBeacon PLC - Dublin-based digital therapeutics company developing project for managing injectable medications - Says it is experiencing unexpected delays in the near-term supply of components for its Smart Sharps bin. "This temporary delay in production will reduce HealthBeacon's 2022 deployment forecast to about 15,000 units," it warns. However, it says it expects the supply chain challenges will be resolved in the fourth quarter of 2022, and that it will achieve 100,000-unit deployment by the end of quarter one 2024.
Chief Executive Officer Jim Joyce says: "Our product is transforming the management of patients on critical injectable medications and our ambition to be a global leader in adherence devices is being realised. Despite these near-term challenges, the company is well positioned for growth in 2023 and beyond."
Current stock price: EUR3.90
12-month change: down 33% from EUR5.85 IPO price in December 2021
By Xindi Wei; xindiwei@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.